Le Jeune Puetz Investment Counsel LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Le Jeune Puetz Investment Counsel LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$110.08 - $142.92 $434,816 - $564,534	-3,950 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$98.85 - $138.91 $128,504 - $180,583	-1,300 Reduced 24.76%	3,950 $549,000
Q2 2021 Jul 27, 2021	SELL	$65.78 - $105.02 $131,560 - $210,040	-2,000 Reduced 27.59%	5,250 $510,000
Q1 2021 Apr 26, 2021	BUY	$64.07 - $91.75 $89,697 - $128,450	1,400 Added 23.93%	7,250 $496,000
Q3 2020 Nov 03, 2020	SELL	$59.04 - $77.95 $466,416 - $615,805	-7,900 Reduced 57.45%	5,850 $380,000
Q2 2020 Aug 03, 2020	BUY	$29.01 - $74.23 $398,887 - $1.02 Million	13,750 New	13,750 $174,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Le Jeune Puetz Investment Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Le Jeune Puetz Investment Counsel LLC with notifications on news.